Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Convertible Debt (2016 - 2019)

BioCorRx's Convertible Debt history spans 7 years, with the latest figure at $4.2 million for Q4 2019.

  • For Q4 2019, Convertible Debt changed N/A year-over-year to $4.2 million; the TTM value through Dec 2019 reached $4.2 million, changed N/A, while the annual FY2019 figure was $4.2 million, N/A changed from the prior year.
  • Convertible Debt for Q4 2019 was $4.2 million at BioCorRx, roughly flat from $4.2 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $4.2 million in Q3 2019 and bottomed at $685.0 in Q3 2015.
  • The 5-year median for Convertible Debt is $791966.0 (2016), against an average of $1.3 million.
  • The largest annual shift saw Convertible Debt skyrocketed 73150.51% in 2016 before it soared 166.2% in 2018.
  • A 5-year view of Convertible Debt shows it stood at $5530.0 in 2015, then soared by 12355.39% to $688783.0 in 2016, then soared by 192.7% to $2.0 million in 2017, then rose by 18.2% to $2.4 million in 2018, then surged by 74.58% to $4.2 million in 2019.
  • Per Business Quant, the three most recent readings for BICX's Convertible Debt are $4.2 million (Q4 2019), $4.2 million (Q3 2019), and $2.4 million (Q1 2018).